| 1 |
Discovery of Potent Neuraminidase Inhibitors Using a Combination of Pharmacophore-Based Virtual Screening and Molecular Simulation Approach
Rohini K, Shanthi V
Applied Biochemistry and Biotechnology, 184(4), 1421, 2018 |
| 2 |
An "All-In-One" Pharmacophoric Architecture for the Discovery of Potential Broad-Spectrum Anti-Flavivirus Drugs
Ncube NB, Ramharack P, Soliman MES
Applied Biochemistry and Biotechnology, 185(3), 799, 2018 |
| 3 |
Drug Design for ALK-Positive NSCLC: an Integrated Pharmacophore-Based 3D QSAR and Virtual Screening Strategy
James N, Shanthi V, Ramanathan K
Applied Biochemistry and Biotechnology, 185(1), 289, 2018 |
| 4 |
Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles
Kouassi AF, Kone M, Keita M, Esmel A, Megnassan E, N'Guessan YT, Frecer V, Miertus S
International Journal of Molecular Sciences, 16(12), 29744, 2015 |
| 5 |
Pharmacophore modeling for hERG channel facilitation
Yamakawa Y, Furutani K, Inanobe A, Ohno Y, Kurachi Y
Biochemical and Biophysical Research Communications, 418(1), 161, 2012 |
